Med Ed Report briefs

Share this article:
Seventy of 156 NIH grantee institutions responding to an OIG investigation have written policies addressing financial interests, and 69 have policies on institutional conflicts. Because NIH lacks insight into the number of financial conflicts of interest among these institutions, the OIG recommended that NIH issue regulations addressing same.

Pri-Med partnered with the American Society for Nutrition on a series of CME sessions designed to help raise PCPs' knowledge and understanding of nutrition-related topics. The series is due to launch at pmiCME Updates Day this month at Pri-Med Conference & Exhibition.

Haymarket Medical Education hired Kenny Cox as VP of educational development, responsible for securing pharma grants. Cox has held a number of executive positions at Primary Care Network.

A February article in Archives of Internal Medicine suggested that ACCME SCS are a “floor not a ceiling” and that more CME providers should stop accepting industry support, or limit it to a small percentage of income, stop using faculty who are also paid speakers or offering courses supported by a single grantor, and use pooled grants.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?